| Date | Title | Description |
| 31.05.2025 | Breast cancer: Pfizer-Arvinas drug beats AstraZeneca’s in delaying disease’s progression | - |
| 29.05.2025 | The Intersection of Biotechnology and Public Health: A Double-Edged Sword | In the world of healthcare, biotechnology stands as a beacon of hope. It’s a realm where science meets innovation, crafting solutions to age-old problems. Yet, this field is not without its shadows. Recent events highlight the delicate bala... |
| 28.05.2025 | These biotech stocks will benefit as generative AI speeds up drug discovery, Jefferies says | - |
| 28.05.2025 | The rest of the world is trouncing the U.S. stock market. Why that could continue | - |
| 27.05.2025 | These strong stocks are under-owned and have momentum, Bank of America says | - |
| 25.05.2025 | Biotechnology Advancements: Revolutionizing Healthcare Through Innovation and Precision | Share
Share
Share
Share
Email
Biotechnology has emerged as a driving force in transforming healthcare. Over the past few decades, the integration of biology with advanced technology has led to significant breakthroughs. These innovations ar... |
| 23.05.2025 | Pfizer's 7.5% Dividend: Income Haven or House of Cards? Pfizer's high dividend yield warrants scrutiny regarding its sustainability, given changing revenues and pipeline investments. | - |
| 23.05.2025 | Nona Biosciences Collaboration Partner Pfizer Announces Presentation of Phase 1 Clinical Study Design on MesoC2, an MSLN-Targeting ADC, at the 2025 ASCO Annual Meeting | CAMBRIDGE, Mass., May 23, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), today announced that its collaborator, Pfizer, will present an abstract ... |
| 22.05.2025 | Bayer, Pfizer, Other Big Global Firms Join Shanghai Open Innovation Initiative | (Yicai) May 22 -- The innovation centers of Germany's Bayer, US' Pfizer, Japan's Sony Group, Denmark's Novo Nordisk, and France's BioMérieux have joined the Group Open Innovation initiative of Pudong District of Shanghai.
The research and d... |
| 22.05.2025 | FDA panel is split on updates to COVID shots as questions loom for fall vaccinations | Other panelists noted that subtype is such a close relative that last year’s shots seem to offer cross-protection, at least for now but with no guarantee there wouldn’t be a different version circulating by the time a vaccination campaign r... |
| 21.05.2025 | Thursday’s big stock stories: What’s likely to move the market in the next trading session | - |
| 21.05.2025 | SK bioscience Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine | No patent infringement found in exports of individual conjugate bulk substances and research-use finished products of PCV13 to Russia
Company plans to export PCV13 vaccine components
"We aim for the global PCV market with our 21-valent... |
| 20.05.2025 | Qorvo's Boardroom Shake-Up: A New Era Begins | In the fast-paced world of technology, change is the only constant. Qorvo, a prominent chipmaker, has recently made headlines by nominating Peter Feld from Starboard Value to its board. This move signals the end of a boardroom battle and a ... |
| 20.05.2025 | New Trump vaccine policy limits access to COVID shots | It’s unclear what the upcoming changes mean for people who may still want a fall COVID-19 shot but don’t clearly fit into one of the categories.
“Is the pharmacist going to determine if you’re in a high-risk group?” asked Dr. Paul Offit, a ... |
| 20.05.2025 | Cellcentric: $120 Million Raised For Treating Multiple Myeloma | CellCentric, a clinical-stage biotechnology company developing inobrodib (a first in class oral cancer drug to treat specific cancers, notably multiple myeloma) announced the completion of a $120 million Series C funding round. The funding ... |
| 19.05.2025 | Qorvo nominates Starboard's Peter Feld to board, ends boardroom battle | Qorvo nominates Starboard's Peter Feld to board, ends boardroom battle
By ReutersMay 19, 202511:42 AM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
A boardroom is seen in an office building in Ma... |
| 19.05.2025 | Qorvo nominates Starboard's Peter Feld to board, ends boardroom battle | Chipmaker Qorvo said on Monday it will nominate activist investor Starboard Value's managing member Peter Feld to its board, ending a boardroom battle as the Apple supplier's stock shows signs of recovery.
Stiff competition and a shift in d... |
| 19.05.2025 | Origin: $21 Million Series A Raised For Global Benefits Intelligence Platform | Origin, the world’s first Global Benefits Intelligence platform, announced it officially launched and it has raised $21 million in Series A funding led by Felix Capital, with participation from Acadian Ventures and Notion Capital. And addit... |
| 19.05.2025 | Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine | Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine
By ReutersMay 19, 202511:34 AM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
Item 1 of 2 A box with the "Nuvaxovid... |
| 17.05.2025 | Here are five ‘high quality’ stocks with major upside, according to Bank of America | - |
| 16.05.2025 | Origin's $21M Series A: A New Dawn for Employee Benefits Management | In the sprawling landscape of employee benefits, chaos often reigns. Companies juggle countless vendors, contracts, and policies, each a puzzle piece in a complex picture. Enter Origin, a UK-based startup that has just raised $21 million in... |
| 16.05.2025 | The Future of Test Automation: A New Era of Efficiency and Quality | In the fast-paced world of software development, time is a precious commodity. Companies are racing to deliver high-quality products faster than ever. Enter the partnership between TTC Global and ACCELQ, a game-changer in the realm of AI-po... |
| 15.05.2025 | A New Era for Australia and the EU: Political Shifts and Transparency Battles | In the ever-shifting landscape of global politics, two significant events have recently emerged from opposite ends of the world. Australia’s Prime Minister Anthony Albanese has secured a second term, while the European Court of Justice has ... |
| 15.05.2025 | Here are ‘Big Short’ Michael Burry’s latest moves in his portfolio | - |
| 15.05.2025 | UK-based Origin raises $21M Series A to tackle fragmented employee benefits | British startup Origin has launched out of stealth with $21 million in Series A funding. The round was led by Felix Capital, with participation from Acadian Ventures, Notion Capital, and a angel investors from across the HR, tech, and enter... |
| 14.05.2025 | Novavax's Path to Approval: A Vaccine's Journey Through Regulatory Hurdles | In the ever-evolving landscape of healthcare, Novavax is navigating a stormy sea. The company, known for its COVID-19 vaccine, is in talks with the FDA, seeking full approval. This dialogue is crucial. It’s the lifeline that could transform... |
| 14.05.2025 | TTC Global and ACCELQ Join Forces to Transform AI-Powered Test Automation | TTC Global, a respected authority in software quality engineering solutions, has partnered with Dallas-based ACCELQ, the innovative AI-powered test automation platform, expanding their successful client engagement, including projects on the... |
| 14.05.2025 | European court sides with NYT over requests for von der Leyen’s texts with Pfizer CEO | The European Court of Justice found that the European Commission failed to explain why text messages with pharmaceutical giant Pfizer CEO should be kept private.
Berlaymont has been closely watching the highly anticipated legal ruling on tr... |
| 14.05.2025 | MARKETERS, MEET ELI: The Emotional Logic Interface That Predicts What Audiences Will Do Before They Do It | Eli From Sooth
A Proprietary AI System That Decodes Human Behavior and Purchasing Decisions, Eli Directs Brands on Who to Prioritize, What to Say and Where to Invest
NEW YORK, May 14, 2025 /PRNewswire-PRWeb/ -- Today, Sooth—the leader in pr... |
| 14.05.2025 | Bastyr University Lists Kenmore Washington Campus For Sale | Bastyr University Kenmore Campus
Bastyr University's Kenmore campus is being listed for sale today. The campus sits on more than 50 acres on the northeast shore of Lake Washington inside Saint Edward State Park. University leadership plans ... |
| 13.05.2025 | Trump’s Drug Price Plan: A Bold Move or a Pipe Dream? | In a bold stroke, President Donald Trump has revived a controversial policy aimed at slashing U.S. drug prices. The plan, known as the “most favored nation” policy, seeks to tie American drug prices to those in other developed countries, wh... |
| 13.05.2025 | The Price of Health: Trump’s Bold Move Against Drug Costs | In a bold stroke, President Donald Trump has taken aim at the soaring prices of prescription drugs in the United States. His recent executive order targets weight-loss medications, specifically the popular drugs Wegovy and Zepbound. The goa... |
| 13.05.2025 |
Cramer’s Lightning Round: Energy Transfer is a buy | Monday - Friday, 6:00 - 7:00 PM ET
It’s that time again! “Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed.
Energy Transfer: [Buy, buy, buy!] The pipes... |
| 13.05.2025 | Trump executive order demands pharma industry price cuts | Trump executive order demands pharma industry price cuts
By Steve Holland, Michael Erman and Patrick WingroveMay 13, 202512:49 AM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
SummaryCompanies
Tr... |
| 12.05.2025 | Trump signs order aiming to cut some U.S. drug prices to match lower ones abroad | President Donald Trump revived a controversial policy that aims to slash drug costs by tying the prices of some medicine in the U.S. to the significantly lower ones abroad.
Trump signed an executive order including several different actions... |
| 12.05.2025 | U.S. stocks with the most China revenue exposure that could win if long-term deal is reached | - |
| 09.05.2025 | The Pulse of Progress: Drug Discovery 2025 in Liverpool | The world of drug discovery is a vibrant tapestry, woven with threads of innovation, collaboration, and hope. This October, Liverpool will host Drug Discovery 2025, a pivotal event that promises to illuminate the path forward in life scienc... |
| 09.05.2025 | The number of ‘tariff’ mentions soar past ‘AI’ on earnings calls as Trump’s trade fight alters outlook | - |
| 09.05.2025 | Novavax says talks with FDA on COVID vaccine approval ongoing calming investor fears | Novavax says talks with FDA on COVID vaccine approval ongoing calming investor fears
By Sriparna RoyMay 8, 20259:34 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
A woman holds a small bottle l... |
| 07.05.2025 | The Landscape of Corporate Acquisitions: Saga Pure ASA's Bold Move | In the world of corporate acquisitions, the stakes are high, and the players are strategic. Saga Pure ASA recently made headlines with its mandatory offer to acquire all outstanding shares of S.D. Standard ETC Plc. This move is not just a t... |
| 07.05.2025 | The Pulse of Progress: DNB's First Quarter Presentation and BioStock Global Forum | In the world of finance and innovation, timing is everything. Two significant events loom on the horizon, each promising to shape the landscape of their respective industries. DNB's first quarter presentation and the BioStock Global Forum a... |
| 07.05.2025 | ELRIG announces keynote speakers for Drug Discovery 2025 | Prof Heather Pinkett and Dr Dafydd Owen to lead ELRIG’s flagship event
Drug Discovery returns to Liverpool, 21–22 October 2025 to celebrate “A Festival of Life Science”
Event supported by VisitBritain showcases UK life science sector and ex... |
| 06.05.2025 | Reviving American Pharma: A Bold Move or a Risky Gamble? | In a landscape where the pharmaceutical industry has become a global chessboard, President Donald Trump has made a significant move. He signed an executive order aimed at revitalizing domestic drug manufacturing. This decision comes at a ti... |
| 06.05.2025 | Commentary: The world is a big step closer to preparing for future pandemics | Listen
8 min
New: You can now listen to articles.
This audio is generated by an AI tool.
SINGAPORE: While most are preoccupied with trade tensions and a fracturing world, a landmark moment in global cooperation has quietly happened.
After m... |
| 06.05.2025 | Pfizer, Novo, Novartis and Genmab are coming to BioStock Global Forum, are you? | Pfizer, Novo, Novartis and Genmab are coming to BioStock Global Forum, are you?
Tue, May 06, 2025 14:52 CET Report this content
Take the opportunity to connect with top life science investors and innovators during this rewarding two-day eve... |
| 06.05.2025 | Critic of drug industry and COVID-19 measures to lead FDA vaccine program | In a social media post, Prasad likened Marks to “a bobblehead doll that just stamps approval.”
Last year, he told former Republican presidential candidate Vivek Ramaswamy that Americans would probably be better off without the FDA in its cu... |
| 05.05.2025 | Trump signs order to boost domestic drug manufacturing as pharma tariffs loom | President Donald Trump signed an executive order to incentivize drug manufacturing in the U.S.
The order comes ahead of Trump’s planned tariffs on pharmaceuticals imported into the U.S.
U.S. production in the pharmaceutical industry has shr... |
| 05.05.2025 | Trump team’s $500 million bet on old vaccine technology puzzles scientists | “This is not a next-generation vaccine,” said Rick Bright, who led HHS’ Biomedical Advanced Research and Development Authority, or BARDA, in the first Trump administration. “It’s so last-generation, or first-generation, it’s mind-blowing.”
... |
| 04.05.2025 | JPMorgan’s favorite stocks heading into May | - |
| 03.05.2025 | The Cost of Health: GLP-1s and the Future of Employer Healthcare | In the world of healthcare, costs often rise like a tide, relentless and overwhelming. But a new wave is forming, one that promises to reshape the landscape of employer-sponsored health plans. This wave is driven by GLP-1 medications, a cla... |
| 03.05.2025 | Eli Lilly and CVS Health: A Tale of Two Giants in the Pharmaceutical Arena | In the ever-evolving landscape of healthcare, two titans, Eli Lilly and CVS Health, have recently made headlines. Their stories are woven with threads of soaring sales, strategic pivots, and cautious optimism. Both companies navigate the st... |
| 02.05.2025 | AI offers vital support for dementia care but risks remain high | - |
| 01.05.2025 | Eli Lilly CEO says company can help ‘respond’ to national security concerns around essential drugs as tariffs loom | Eli Lilly CEO Dave Ricks said the drugmaker can help “respond” to national security concerns around cheaper essential medicines as pharmaceutical-specific tariffs loom.
The Trump administration has opened an investigation into how importing... |
| 01.05.2025 | CVS tops estimates, hikes guidance as insurance business shows some improvement | CVS Health reported first-quarter revenue and profit that topped estimates and hiked its guidance, as its troubled insurance business showed some improvement during the period.
The company now expects full-year adjusted earnings of $6 to $6... |
| 30.04.2025 | US stocks rally as Trump tempers auto tariffs | NEW YORK: Wall Street stocks rose Tuesday (Apr 29) as markets digested mixed earnings while applauding a move by President Donald Trump to ease tariffs on automakers.
Trump's pivot includes limitations on the impact of multiple tariffs on c... |
| 30.04.2025 | GLP-1s can help employers lower medical costs in 2 years, new study finds | Aon researchers found that within two years, improved health outcomes for patients who were taking GLP-1 drugs lowers the growth rate of medical care costs.
Aon looked at medical claims data for 139,000 U.S.-based workers with employer heal... |
| 30.04.2025 | Everest Medicines Announces New Drug Application Approval of VELSIPITY® for Adults with Moderately to Severely Active Ulcerative Colitis in Hong Kong | SHANGHAI, April 30, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of ... |
| 29.04.2025 | Перечень жизненно важных лекарств не резиновый | - |
| 29.04.2025 | Stocks making the biggest moves midday: Spotify, Regeneron, Hims & Hers, Pfizer and more | - |
| 28.04.2025 | Фармрынок идет на поправку | - |
| 28.04.2025 | The worst (and best) stocks during Trump’s tough first 100 days | - |
| 28.04.2025 | Nona Biosciences' Partner Pfizer Presents Preclinical Data on TOP1i-Based ADC Targeting MSLN at AACR Annual Meeting 2025 | CAMBRIDGE, Mass., April 28, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), today announced that its partner, Pfizer, has presented preclinical da... |
| 28.04.2025 | FDA scrutiny of Novavax COVID-19 vaccine sparks uncertainty about other shots | Kennedy won Senate confirmation to his job, in part, by promising not to change the nation’s vaccine schedule. Since taking office, he’s promised to “investigate” children’s shots, canceled meetings of expert vaccine advisers and directed o... |
| 28.04.2025 | 5 things to know before the stock market opens Monday | Stock futures slid Monday, but the major U.S. indexes have recovered much of what they lost after President Donald Trump announced steep tariffs on dozens of countries early this month.
It’s the busiest week of first-quarter earnings season... |
| 28.04.2025 | Tuesday’s big stock stories: What’s likely to move the market in the next trading session | - |
| 26.04.2025 | The Vaccine Tug-of-War: Novavax's Path to Approval Amidst Political Storms | In the world of vaccines, the stakes are high. Novavax, a player in the COVID-19 vaccine arena, is navigating a turbulent sea. The company recently announced that its COVID-19 shot is on track for full approval from the FDA. But the journey... |
| 26.04.2025 | Ivonescimab Receives NMPA Approval for First-Line Treatment of PD-L1-Positive NSCLC, Based on Breakthrough Head to Head Phase III Trial Demonstrating Superior Efficacy Over Pembrolizumab | HONG KONG, April 26, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that its globally first-in-class PD-1/VEGF bispecific antibody, ivonescimab, has received approval from th... |
| 25.04.2025 | Exclusive: US pharma tariffs would raise US drug costs by $51 billion annually, report finds | Exclusive: US pharma tariffs would raise US drug costs by $51 billion annually, report finds
By Maggie FickApril 25, 20254:34 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
U.S. dollar banknote... |
| 25.04.2025 | Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic | Novo Nordisk scored a huge legal victory that largely restricts compounding pharmacies from marketing or selling cheaper, unapproved versions of the drugmaker’s blockbuster weight loss drug Wegovy and diabetes treatment Ozempic.
U.S. Distri... |
| 24.04.2025 | Merck lowers profit outlook, partly due to $200 million expected tariff hit | Merck lowered its full-year profit guidance, citing a charge tied to a recent licensing deal and $200 million in estimated additional costs for tariffs implemented to date.
The company said the expected tariff charge primarily reflects levi... |
| 23.04.2025 | Thursday’s big stock stories: What’s likely to move the market in the next trading session | - |
| 23.04.2025 | Novavax says its COVID-19 shot is on track for full FDA approval after delay | But FDA’s acting commissioner, Dr. Sara Brenner, directed the agency’s lead official overseeing the vaccine to pause the decision, according to one of the people. The delay, first reported by The Wall Street Journal, sparked concerns of pol... |
| 23.04.2025 | Goldman likes these buy-rated stocks with solid dividend yields | - |
| 21.04.2025 | Tuesday’s big stock stories: What’s likely to move the market in the next trading session | - |
| 17.04.2025 | The China-U.S. trade war has investors bracing for more pain in both markets | - |
| 17.04.2025 | Goldman Sachs says buy call options on these stocks ahead of earnings | - |
| 17.04.2025 | Thursday’s big stock stories: What’s likely to move the market in the next trading session | - |
| 17.04.2025 | Brain implant cleared by FDA for Precision Neuroscience, a Musk Neuralink rival | Precision Neuroscience announced that a core component of its brain implant system has been approved by the U.S. Food and Drug Administration.
The company is building a brain-computer interface that will eventually help paralyzed patients r... |
| 17.04.2025 | World Hemophilia Day 2025 - April 17, 2025 - "Access for all: Women and girls bleed too" | MONTREAL, April 17, 2025 /PRNewswire/ -- On April 17, 2025, the global bleeding disorders community will come together under the theme "Access for all: Women and girls bleed too" and celebrate World Hemophilia Day. Today, women an... |
| 17.04.2025 | 23andMe bankruptcy under congressional investigation for customer data | The House Committee on Energy and Commerce sent a letter to 23andMe expressing concern that its genetic data is “at risk of being compromised.”
The embattled genetic testing company filed for Chapter 11 bankruptcy protection in March, and i... |
| 17.04.2025 | Lilly weight-loss pill works as well as Ozempic, shares surge | Lilly weight-loss pill works as well as Ozempic, shares surge
By Deena Beasley and Manas MishraApril 17, 20254:02 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
The logo of Lilly is seen on a w... |
| 16.04.2025 | Brace for more volatility with these defensive trades | - |
| 15.04.2025 | Назад, в генетическое будущее | - |
| 15.04.2025 | Key vaccine committee meets for the first time under Robert F. Kennedy Jr. | CDC official asks about COVID-19 vaccines
The conversation took a turn when a CDC official summarized a committee workgroup discussion about the waning COVID-19 pandemic, and asked whether the panel might consider changing vaccination recom... |
| 15.04.2025 | CNBC Daily Open: Consumers are worried over the economy. The White House insists it’ll be fine | A day without major tariff developments from U.S. President Donald Trump’s administration is, for markets, a day of cautious optimism (or at least what passes as “optimism” in such unusual times). There was breathing room on Monday for mark... |
| 14.04.2025 | Pfizer scraps daily weight loss pill after liver injury in one patient | Pfizer said it would end development of its experimental daily weight loss pill after a patient experienced a liver injury that was potentially caused by the drug in a trial.
The patient’s liver enzymes “recovered rapidly” after they stoppe... |
| 14.04.2025 | 5 things to know before the stock market opens Monday | Markets have been on a wild ride.
Trump exempted smartphones, computers and other tech devices and components from his so-called reciprocal tariffs.
Earnings season kicks off in earnest with big banks continuing to report along with Netflix... |
| 14.04.2025 | Stocks making the biggest moves premarket: Apple, Nvidia, Goldman Sachs, Pfizer and more | - |
| 14.04.2025 | Pfizer halts development of weight-loss pill | - |
| 14.04.2025 | Pfizer ends development of potential pill obesity treatment | But leading treatments like Zepbound and Novo Nordisk’s Wegovy are injectable. Drugmakers are eager to develop an easier-to-take pill version for patients who don’t want to deal with needles and daily injections.
Lilly researchers expect to... |
| 13.04.2025 | Goldman says these names can rally this earnings season after likely topping expectations | - |
| 12.04.2025 | The Melanoma Research Foundation to host the DC Miles for Melanoma 5K | The Melanoma Research Foundation (MRF) is thrilled to announce one of the first events in its annual Miles for Melanoma nationwide 5K program, bringing together local melanoma patients, supporters, care partners and thrivers. This year we w... |
| 11.04.2025 | Tariff Turmoil: The Unraveling of U.S.-China Trade Relations and Its Impact on the Aerospace Industry | The world of trade is a chess game, and right now, the pieces are scattered. The U.S. and China are locked in a fierce battle, and the stakes are high. Tariffs are the weapons of choice, and the aerospace industry is caught in the crossfire... |
| 11.04.2025 | Cramer looks at what’s holding the market back — plus, stocks that should be doing better | - |
| 11.04.2025 | China will raise tariffs on US goods from 84% to 125%, the latest in an escalating trade war | Chinese tariffs will affect goods like soybeans, aircrafts and their parts and drugs — all among the country’s major imports from the U.S. Beijing, meanwhile, suspended sorghum, poultry and bonemeal imports from some American companies last... |
| 10.04.2025 | Tariff Turmoil: The Pharmaceutical Industry Faces a Storm | The pharmaceutical industry is in the eye of a storm. President Donald Trump has thrown a wrench into the works with his proposed tariffs on drug imports. The news sent shockwaves through global markets, causing shares of major pharmaceutic... |
| 10.04.2025 | Longevity and precision medicine driving the agenda at Abu Dhabi Global Health Week | Global initiative addressing personalised and preventative health to be launched during the event
ABU DHABI, UAE, April 10, 2025 /PRNewswire/ -- With rising global demand for more personalised and effective healthcare solutions, the Departm... |
| 10.04.2025 | Global pharma shares plunge as Trump doubles down on tariff threat | Global drugmakers' stocks dropped across the board after US President Donald Trump reiterated plans for a "major" tariff on pharmaceutical imports, threatening an interwoven global supply chain, and as his country-specific recipro... |
| 09.04.2025 | Pharmaceutical stocks rise as Trump pauses tariffs but not for China | Some pharmaceutical stocks rose after President Donald Trump said he would pause most so-called reciprocal tariffs, temporarily easing fears about the impact of potential tariffs on pharmaceuticals .
Shares of most U.S.-based companies turn... |
| 09.04.2025 | Stocks making the biggest moves premarket: Walmart, Target, Apple, Pfizer, Eli Lilly, Ford and more | - |
